These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 29408336)
1. Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1. Zhu HY; Bai WD; Ye XM; Yang AG; Jia LT Biochem Biophys Res Commun; 2018 Feb; 496(4):1308-1313. PubMed ID: 29408336 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop. Li X; Wu Y; Liu A; Tang X Tumour Biol; 2016 Nov; 37(11):14733-14743. PubMed ID: 27629141 [TBL] [Abstract][Full Text] [Related]
3. [Urothelial carcinoma-associated 1 enhances tamoxifen resistance in breast cancer cells through competitively inhibiting miR-18a]. Li XN; Liu AH; Tang X; Ren Y Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):295-302. PubMed ID: 28416841 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143. Tuo YL; Li XM; Luo J Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3403-11. PubMed ID: 26439035 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway. Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R. Ye XM; Zhu HY; Bai WD; Wang T; Wang L; Chen Y; Yang AG; Jia LT BMC Cancer; 2014 Feb; 14():134. PubMed ID: 24571711 [TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b. Fang Q; Chen X; Zhi X Med Sci Monit; 2016 Oct; 22():3506-3513. PubMed ID: 27694794 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA UCA1 upregulation promotes the migration of hypoxia-resistant gastric cancer cells through the miR-7-5p/EGFR axis. Yang Z; Shi X; Li C; Wang X; Hou K; Li Z; Zhang X; Fan Y; Qu X; Che X; Liu Y Exp Cell Res; 2018 Jul; 368(2):194-201. PubMed ID: 29723509 [TBL] [Abstract][Full Text] [Related]
9. The UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells. Wang X; Yang B; Ma B Cancer Chemother Pharmacol; 2016 Nov; 78(5):1025-1031. PubMed ID: 27686228 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19. Zheng P; Dong L; Zhang B; Dai J; Zhang Y; Wang Y; Qin S Histochem Cell Biol; 2019 Oct; 152(4):281-291. PubMed ID: 31352515 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA UCA1 promotes lung cancer cell proliferation and migration via microRNA-193a/HMGB1 axis. Wu H; Zhou C Biochem Biophys Res Commun; 2018 Feb; 496(2):738-745. PubMed ID: 29355524 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer. Li W; Zhai L; Wang H; Liu C; Zhang J; Chen W; Wei Q Oncotarget; 2016 May; 7(19):27778-86. PubMed ID: 27034004 [TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway. Wu C; Luo J Med Sci Monit; 2016 Oct; 22():3860-3867. PubMed ID: 27765938 [TBL] [Abstract][Full Text] [Related]
14. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer. Dong H; Wang W; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J Int J Oncol; 2018 Sep; 53(3):1013-1026. PubMed ID: 30015837 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030 [TBL] [Abstract][Full Text] [Related]
16. Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway. Li Z; Yu D; Li H; Lv Y; Li S Int J Oncol; 2019 Mar; 54(3):1033-1042. PubMed ID: 30628639 [TBL] [Abstract][Full Text] [Related]
17. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis. Wang J; Ye C; Liu J; Hu Y Biochem Biophys Res Commun; 2018 Jul; 501(4):1034-1040. PubMed ID: 29777711 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA UCA1 enhances sensitivity to oncolytic vaccinia virus by sponging miR-18a/miR-182 and modulating the Cdc42/filopodia axis in colorectal cancer. Horita K; Kurosaki H; Nakatake M; Ito M; Kono H; Nakamura T Biochem Biophys Res Commun; 2019 Aug; 516(3):831-838. PubMed ID: 31262449 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway. Zhang Y; Liu Y; Xu X J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500 [TBL] [Abstract][Full Text] [Related]
20. Roles of lncRNA UCA1-miR-18a-SOX6 axis in preventing hypoxia injury following cerebral ischemia. Tian J; Xu H; Chen G; Wang H; Bi Y; Gao H; Luo Y Int J Clin Exp Pathol; 2017; 10(8):8187-8198. PubMed ID: 31966670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]